Hill-Rom Holdings Revenue 2006-2020 | HRC

Hill-Rom Holdings annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Hill-Rom Holdings revenue for the quarter ending June 30, 2020 was $0.768B, a 5.6% increase year-over-year.
  • Hill-Rom Holdings revenue for the twelve months ending June 30, 2020 was $2.959B, a 2.59% increase year-over-year.
  • Hill-Rom Holdings annual revenue for 2019 was $2.907B, a 2.08% increase from 2018.
  • Hill-Rom Holdings annual revenue for 2018 was $2.848B, a 3.8% increase from 2017.
  • Hill-Rom Holdings annual revenue for 2017 was $2.744B, a 3.33% increase from 2016.
Hill-Rom Holdings Annual Revenue
(Millions of US $)
2019 $2,907
2018 $2,848
2017 $2,744
2016 $2,655
2015 $1,988
2014 $1,686
2013 $1,716
2012 $1,634
2011 $1,592
2010 $1,470
2009 $1,387
2008 $1,508
2007 $1,357
2006 $1,288
2005 $1,938
Hill-Rom Holdings Quarterly Revenue
(Millions of US $)
2020-06-30 $768
2020-03-31 $723
2019-12-31 $685
2019-09-30 $783
2019-06-30 $727
2019-03-31 $714
2018-12-31 $684
2018-09-30 $759
2018-06-30 $709
2018-03-31 $711
2017-12-31 $670
2017-09-30 $738
2017-06-30 $689
2017-03-31 $679
2016-12-31 $637
2016-09-30 $706
2016-06-30 $655
2016-03-31 $633
2015-12-31 $661
2015-09-30 $574
2015-06-30 $475
2015-03-31 $475
2014-12-31 $465
2014-09-30 $480
2014-06-30 $398
2014-03-31 $415
2013-12-31 $393
2013-09-30 $438
2013-06-30 $424
2013-03-31 $426
2012-12-31 $428
2012-09-30 $432
2012-06-30 $407
2012-03-31 $415
2011-12-31 $381
2011-09-30 $431
2011-06-30 $385
2011-03-31 $402
2010-12-31 $374
2010-09-30 $397
2010-06-30 $361
2010-03-31 $357
2009-12-31 $355
2009-09-30 $363
2009-06-30 $335
2009-03-31 $337
2008-12-31 $352
2008-09-30 $424
2008-06-30 $367
2008-03-31 $375
2007-12-31 $341
2007-09-30 $530
2007-06-30 $329
2007-03-31 $335
2006-12-31 $483
2006-09-30 $521
2006-06-30 $469
2006-03-31 $496
2005-12-31 $478
2005-09-30 $497
2005-06-30 $466
2005-03-31 $501
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.471B $2.907B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.017B 33.44
Medtronic (MDT) Ireland $129.409B 21.02
Stryker (SYK) United States $72.454B 28.10
Boston Scientific (BSX) United States $53.973B 31.88
Lonza Group Ag (LZAGY) Switzerland $46.320B 0.00
Baxter (BAX) United States $43.728B 0.00
ResMed (RMD) United States $29.297B 46.24
EssilorLuxottica Societe Anonyme (ESLOY) France $28.981B 0.00
Terumo (TRUMY) Japan $28.862B 36.89
Zimmer Biomet Holdings (ZBH) United States $27.836B 17.51
Sunny Optical Technology (SNPTF) China $20.336B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.428B 0.00
Bio-Rad Laboratories (BIO) United States $15.561B 70.46
Insulet (PODD) United States $12.829B 1271.00
Shandong Weigao Medical Polymer (SHWGF) China $12.301B 0.00
Quidel (QDEL) United States $11.863B 62.77
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $7.981B 40.68
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.227B 12.93
Canopy Growth (CGC) Canada $6.779B 0.00
Haemonetics (HAE) United States $4.409B 26.48
Neogen (NEOG) United States $4.066B 67.94
GW Pharmaceuticals (GWPH) United Kingdom $3.963B 0.00
ICU Medical (ICUI) United States $3.828B 27.92
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.617B 0.00
Envista Holdings (NVST) United States $3.486B 23.77
Abcam (ABCZY) $3.456B 0.00
Agios Pharmaceuticals (AGIO) United States $3.132B 0.00
NuVasive (NUVA) United States $2.929B 23.51
National Vision Holdings (EYE) United States $2.568B 44.43
TG Therapeutics (TGTX) United States $2.157B 0.00
AtriCure (ATRC) United States $1.834B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.627B 0.00
Aphria (APHA) Canada $1.374B 0.00
NanoString Technologies (NSTG) United States $1.362B 0.00
MacroGenics (MGNX) United States $1.248B 0.00
Aurora Cannabis (ACB) Canada $1.176B 0.00
Cerus (CERS) United States $1.169B 0.00
OraSure Technologies (OSUR) United States $1.127B 226.88
Vapotherm (VAPO) United States $1.113B 0.00
Cardiovascular Systems (CSII) United States $1.075B 0.00
Meridian Bioscience (VIVO) United States $1.049B 39.50
PetIQ (PETQ) United States $1.036B 29.91
InMode (INMD) Israel $1.035B 21.86
Owens & Minor (OMI) United States $1.013B 26.80
Phibro Animal Health (PAHC) United States $0.938B 18.71
Quanterix (QTRX) United States $0.915B 0.00
Omeros (OMER) United States $0.699B 0.00
Zynex (ZYXI) United States $0.664B 57.94
Surmodics (SRDX) United States $0.643B 77.53
Eagle Pharmaceuticals (EGRX) United States $0.635B 45.48
BioLife Solutions (BLFS) United States $0.617B 175.73
VAREX IMAGING (VREX) United States $0.613B 15.22
LeMaitre Vascular (LMAT) United States $0.592B 36.21
Lantheus Holdings (LNTH) United States $0.536B 12.48
Viemed Healthcare (VMD) United States $0.421B 37.38
Cytosorbents (CTSO) United States $0.347B 0.00
HEXO (HEXO) $0.313B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.308B 0.00
Utah Medical Products (UTMD) United States $0.297B 25.47
Organigram Holdings (OGI) Canada $0.216B 0.00
Chimerix (CMRX) United States $0.193B 0.00
Female Health (VERU) United States $0.192B 0.00
Fonar (FONR) United States $0.159B 14.07
Exagen (XGN) United States $0.157B 0.00
Bovie Medical (APYX) United States $0.153B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Wound Management Technologies (SMTI) United States $0.132B 0.00
Liberty Health Sciences (LHSIF) Canada $0.126B 0.00
Rockwell Medical (RMTI) United States $0.119B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.116B 0.00
Capricor Therapeutics (CAPR) United States $0.114B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Evolus (EOLS) United States $0.110B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.066B 15.34
Brainsway (BWAY) Israel $0.064B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Akers Biosciences Inc (AKER) United States $0.032B 0.00
FSD PHARMA INC (HUGE) Canada $0.032B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00